Deferred publication: Advanced NSCLCLBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) results
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 European Lung Cancer Conference organisers, ESMO and IASLC. Published by Elsevier Inc. All rights reserved.